#

Dailypharm Live Search Close
  • Lee to pledge ‘incentives for homegrown new drugs'
  • by Lee, Jeong-Hwan | translator Alice Kang | 2022-02-16 05:51:51
as well as the system for e-prescriptions as election pledge
“Is reviewing innovative policies including a mega fund for the pharmaceutical industry and preapproval of ultra-high-priced drugs”

Presidential candidate Jae-Myung Lee of the Democratic Party of Korea is positively reviewing reinforcing incentives for new drugs that were developed by Korean pharmaceutical companies or conducted trials in Korea, establishing a megafund for the pharmaceutical industry, and introducing a pre-approval system for prescriptions of ultra-high priced drugs as pledges for the coming presidential election this year.

 

Also, the candidate is preparing to set official pledges on establishing a public electronic prescription system, institutionalize government support for public late-night pharmacies and complete eradication of hospitals owned by non-medical personnel.

 

The pledges above were those requested by the domestic pharmaceutical industry, pharmacists’ association, and medical field and gained consensus from the NA Health and Welfare Committee.

 

Lee plans to disclose the details of the policy in line with the official electioneering period that starts on the 15th.

 

Lee is known to be reviewing various specific healthcare policies that require expertise regarding non-face-to-face treatment, biopharmaceutical industry, and pharmacy industry, in addition to the public healthcare pledges that he repeatedly announced including the expansion of public hospitals and reinforcing public medical personnel.

 

In particular, the candidate is known to have drawn a relatively detailed blueprint on the development of homegrown vaccines that have greatly increased in importance due to the prolonged COVID-19 pandemic, public manufacture of essential medicines, and national support for the pharmaceutical and bio-industry are being.

 

More specifically, the candidate is likely to make pledges to increase the vaccine self-sufficiency rate of vaccines in the National Immunization Program and strengthen the financial and administrative support needed for the treatment of COVID-19 vaccine and treatments while building a public manufacturing system for essential drugs that are at risk of supply disruption due to low profitability.

 

Also, the candidate is considering incentive systems and active state-driven investment in the pharmaceutical and bio-industry to make Korea a pharmaceutical and biopharmaceutical powerhouse.

 

Lee’s plan is to establish create a public-private matching-fund type megafund to improve the support system for clinical trials and realign the compensation system for homegrown new drugs and clinical trials conducted in Korea.

 

Also, enhancing patient access to new drugs and pre-approval system for prescriptions of ultra-high-risk or ultra-high-priced drugs are being considered as pledges.

 

The pledges above were those that multinational pharmaceutical companies with subsidiaries in Korea had continuously requested to the National Assembly and the government.

 

In particular, the policies requested by Korea Pharmaceutical Association and pharmacists around are also expected to be included in Lee’s pledge.

 

Policies that establish a system for non-face-to-face healthcare that has been temporarily approved due to COVID-19 and promote a state-led public e-prescription system, and policies to expand accessibility and convenience to medication for patients with public late-night pharmacies.

 

The state-led public electronic prescription transmission system has been a policy that KPA had requested for several years now.

 

The public late-night pharmacies are being piloted this year after securing a budget the previous year.

 

Lee’s aim is to expand this pilot project into a main project.

 

In addition, to completely eradicate hospitals owned by non-medical personnel, pledges to allow judicial police power to the NHIS, voluntary reporting, immunity for whistleblowers, stronger report rewards, punishment for those who made illegal establishments, and stronger recovery of unlawful profits are also expected to be included in the manifesto.

 

Also, Lee’s camp promised to fully include ‘small/clear happiness pledges’ Lee had made as health insurance reimbursement of hair loss treatments, contraception, and abortion, free vaccination of HPV vaccines in adolescents, and soft landing the legalization of CCTVs in the operating room.

 

An official from Lee’s camp said, “The camp is busy making additional modifications and final touches to the manifesto.

 

We are in the healthcare pledges are in the final stages, and review the general improvements required in healthcare from public Healthcare to pharmaceutical and bio-industry, to patient systems at hospitals and pharmacies in Korea.

 

The official added, “due to the diverse and multifaceted range of pledges that are being discussed by Lee’s camp, some have been producing false news that Lee excluded the reimbursement pledge for hair loss drugs based on the draft prepared by the camp.

 

The completed pledge manifesto will be disclosed on the 15th when the official election campaign begins."

 

  • 0
Reader Comment
0
Member comment Write Operate Rule
Colse

댓글 운영방식은

댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.

댓글 노출방식은

댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.

댓글의 삭제 기준은

다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.

  • 저작권·인격권 등 타인의 권리를 침해하는 경우

    상용 프로그램의 등록과 게재, 배포를 안내하는 게시물

    타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물

  • 근거 없는 비방·명예를 훼손하는 게시물

    특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우

    특정 지역 및 종교간의 감정대립을 조장하는 내용

    사실 확인이 안된 소문을 유포 시키는 경우

    욕설과 비어, 속어를 담은 내용

    정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)

    특정 지역이나 단체를 비하하는 경우

    특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우

    특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우

    타인의 ID 혹은 닉네임을 도용하는 경우

  • 게시판 특성상 제한되는 내용

    서비스 주제와 맞지 않는 내용의 글을 게재한 경우

    동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우

    부분적으로 변경하여 반복 게재하는 경우도 포함

    제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우

    돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물

    게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우

  • 수사기관 등의 공식적인 요청이 있는 경우

  • 기타사항

    각 서비스의 필요성에 따라 미리 공지한 경우

    기타 법률에 저촉되는 정보 게재를 목적으로 할 경우

    기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용

  • 사실 관계 확인 후 삭제

    저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우

    타인의 초상권을 침해하거나 개인정보를 유출하는 경우

    당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)

  • ※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.

    ※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.

    ※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.

If you want to see the full article, please JOIN US (click)